AI Article Synopsis
- Dermatochalasis is a condition often linked to aging that causes both functional and cosmetic issues for individuals, with various treatment options like blepharoplasty and laser therapy available.
- The study aimed to assess the effectiveness of plasma exeresis, a non-surgical method, in treating dermatochalasis in the upper eyelid among 40 female patients who underwent three treatment sessions spaced one month apart.
- Results showed significant improvements in eyelid laxity and marginal crease distance, with 90% of patients experiencing noticeable changes, indicating that plasma exeresis could be a safe and effective treatment option for mild to moderate cases of dermatochalasis.
Article Abstract
Background: Dermatochalasis is frequently associated with tissue ageing and leads to multiple functional and cosmetic issues. There are several possible medical and surgical treatments available, such as blepharoplasty and laser therapy.
Objective: The aim of this work was to evaluate plasma exeresis as a new technique for nonsurgical treatment of dermatochalasis of the upper eyelid.
Patient And Methods: This clinical trial included 40 female patients with dermatochalasis. Each patient received 3 sessions of treatment with the technology of plasma exeresis with one-month interval. Final evaluation was performed three months after the last session by 2 blinded dermatologists and 2 ophthalmologists, lid laxity according to facial laxity rating scale (FLRS), marginal crease distance (MCD) before and after treatment and patient satisfaction score.
Results: There was a significant decrease in eye lid laxity (FLRS) after treatment where < .001; 36 (90%) patients had change and 4 (10%) patients without change in general. There was a significant increase in MCD after treatment ( = .001).
Conclusion: Plasma exeresis seems to improve appearance of the upper eyelid, without any serious adverse events and could be a valid solution for dermatochalasis especially in mild and moderate cases.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1080/09546634.2020.1800569 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Ablative radiofrequency microplasma for lateral dermatochalasis-indications and treatment recommendations.
Lasers Med Sci
December 2024
Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
To determine in which cases ablative radiofrequency microplasma is preferred for the treatment of lateral dermatochalasis over a surgical approach as well as discussing each method's benefits and limitations. Twenty-one patients underwent 3 interventions of plasma exeresis. Photographic and RCM images were acquired at baseline and 4 weeks after final plasma exeresis.
View Article and Find Full Text PDFPlasma Exeresis for the Treatment of Benign Eyelid Lesions: A New Surgical Approach.
Ophthalmic Plast Reconstr Surg
September 2024
Ophthalmology Department, Konyagoz Eye Hospital, Konya, Turkey.
Purpose: To report the plasma therapy technique and its clinical outcomes in patients with benign eyelid lesions.
Methods: This is a retrospective, noncomparative, interventional study. The study included 71 eyes of 66 patients who underwent plasma exeresis for benign eyelid lesions in our clinic between February 2018 and December 2022.
Comparing the efficacy of plasma exeresis and cryotherapy for the treatment of seborrheic keratosis: A randomized controlled trial.
Skin Res Technol
August 2023
Laser and Plasma Research Institute, Shahid Beheshti University, Tehran, Iran.
Article Synopsis
- - The study compares plasma exeresis and cryotherapy in treating seborrheic keratoses, a benign skin tumor, through a randomized controlled trial involving 35 males.
- - At the 6-week mark, plasma exeresis cleared significantly more lesions (57.1%) compared to cryotherapy (20.7%), although some differences in clarity at week 3 were not statistically significant.
- - Both treatments showed similar side effects, mainly erythema and hypo pigmentation, and both were found to be effective, with plasma exeresis proving to be superior in the long term.
Keloid Treatment Using Plasma Exeresis: A Pilot Trial Study.
J Lasers Med Sci
March 2023
Dermatology Department, Faculty of Medicine Tehran Medical Sciences, Islamic Azad University, Tehran, Iran.
Keloid scars and hypertrophic scars are more commonly seen after surgeries, suture placements, or other skin damages. Scars can be treated using a variety of methods, including topical compounds, surgery, and lasers. The aim of this study is to evaluate the effects of plasma exeresis on the treatment of keloid scars.
View Article and Find Full Text PDFModern blepharoplasty: From bench to bedside.
World J Clin Cases
March 2023
Department of Plastic Surgery, University Hospital of Udine, Udine 33100, Italy.
The demand for procedures aiming to rejuvenate the upper third part of the face and the periocular region has increased in the past several years. Blepharoplasty is one of the most frequently performed procedures worldwide to date. Surgery is currently the first choice in order to achieve permanent and effective results; however, it is burdened by potential surgical complications feared by patients.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!